>PROKKA_00001 hypothetical protein
MKYIYNPLVDTFNNMYKTYKPLIDLAEHNKAITKLINIPISKNKLQRYDILLRQIKPLKD
RYTCYHYTPLNVKIININLNKIDLNCLQNCVSKCKFRHLQGYNNKLNKNKATVNIKHITY
IDEHSINKILHQVVNKLDSEEERKLFLWVISLIEDSIKENQSKTT*
>PROKKA_00002 putative hydrolase
VNKELIIEKTKEYVKSRLEGEGSGHDWYHILRVYNNAIDIARNEESVDIFIVKLGALLHD
IADHKFGYNDDDRKNIISGFLSKYDVSQEDIKEVVYITNYISFKGGKNNHVMKSIEGKIV
QDADRLDAMGAIGISRAFTYGGYINRPMYDVNPNNIEHEKRDGYINTDTITHFYEKLLLL
KDRMNTNTGRKKAIIRHKTMEMFLDMFFKEWNGEI*
>PROKKA_00003 transcriptional regulator BotR, P-21
MNDLFYAIENLKHDNQHFDFIEMYLKKYIEKTSKKYNLYYDYYNDILYHLWKEVIEINLK
NFNSELDLRKYISTSIKRYCINICKKKNRNKKIIYNSEVTYKKLESVKGDSLYCGNFEFL
DLISILNYKEKQIIYMKFFECRKDNEIARRLHLSRQSIYKIRIKSLKKLYPIVMQLVNI*
>PROKKA_00004 Hemagglutinin components HA-22/23/53 precursor
MSLSIKELYYTKDKSINNVNLADGNYVVNRGDGWILSRQNQNLGGNISNNGCTAIVGDLR
IRETATPYYYPTASFNEEYIRNNVQNVFANFTEASEIPIGFEFSKTAPSNKGLYMYLQYT
YIRYEIIKVLRNTVIERAVLYVPSLGYAKSIEFNSGEQIDKNFYFTSEDKCILNEKFIYK
KIAETTTAKESNDSNNTTNLNTSQTILPYPNGLYVINKGDGYMRTNDKDLIGTLLIETNT
SGSIIQPRLRNTTRPLFNTSNPTLFSQEYTEARLNDAFNIQLFNTSTTLFKFVEEAPDNK
NISMKAYNTYEKYELINYQDGNIADKAEYYLPSLGKCEVSDAPSPQEPVVETPVDQDGFI
QTGPNENIIVGVINPSENIEEISTPIPDDYTYNIPTSIQNNECYVLFKVNTTGVYKITTK
NNLPPLIIYEAIGSSNRNMNLNNLSNDNIKAIKYITGLNRSDAKSYLVVSLFKDKNYYIR
IPQIPSSTTNQINFKRDLENLQILADSTVNIIDNLNSSGLHYYTRQSPDVGDYISYEFII
PGNFNNKDKSNLILYTTNNQSNGDLYRVTESINGYNLINIKSYSSLLNNNESIQLLNGAI
YILKVKITQLNNYNIRFNINITN*
>PROKKA_00005 HA 17 kDa subunit
MSSERTFLPNGNYKIKSLFSDSLYLTYSSGSLSFLNTSSLDNQKWKLEYISSSNGFRFSN
VAESNKYLAYNDYGFIYLSSSSNNSLWNPIKIAINSYIICTLSIVNVTDYAWTIYDNNNN
ITNQPILNLPNFDINNSSQILKLEKL*
>PROKKA_00006 hypothetical protein
MSQTNANDLRNNEVFFISPSNNTNKVLDKISQNEVKLWNKLSGANQKWRLIYDTNKQAYK
IKVMDNTSLILTWDAPLSSVSVKTDTNTNNQYWYLLQDYISRNVIIRSYMNPNLVLQYNT
DDTLIISTQTSSNNQFFKFFNSIYTDFNNQNCKIATLLNTNKLLSKQLNNNDVVLWEQFD
SNRQKWKILYNESKMAYTLTCIENNEYLTWFSNTGNNVGTYRTEDNNDQYWFINYLNNDA
SMYTLSNFSDSNKFLDVLDSGTSNGTNVQVWNRNGNNAQKWIITRL*
>PROKKA_00007 Botulinum neurotoxin type E precursor
MDINDDLNINSPVDNKNVVIVRARKTNTFFKAFKVAPNIWVAPERYYGEPLDIAEEYKLD
GGIYDSNFLSQDSEREKFLQAIITLLKRINNTIAGKQLLSLISTAIPFPYGYVGGGYSSP
NIFTFGKTPKSNKKLNSLVTSTIPFPFGGYRETNYIESPNNKDFYASNIVIFGPGSNIVE
NNVICYKKNDAENGMGTMAEILFQPLLTYKYNKFYIDPAMELTKCLIKSLYFLYGIKPSD
GLVVPYRLRTELDNKQFSQLNIIDLLISGGVDLEFINTNPYWFTNSYFSNSIKMFEKYKN
IYETEIEGNNAIGNDIKLRLRQKFQNSVQDIWNLNLNYFSKEFNSIIPDRFSNALKHFYR
KQYYTMDYTDNYNINGFVNGQINTKLPLSDKNTNIISKPEKVVNLVNENNISLMKSNIYG
DGLKGTTEDFYSTYKIPYNEEYEYRFNDSDNFPLNNISIEEVDSIPEIIDINPYKDNSDN
LVFTQITSMTEEVTTHTALPINYLQAQITTNENFTLSSDFSKVVSSKDKSLVYSFLDNLM
SYLETIKNDGPIDTDKKYYLWLKEVFKNYSFDINLTQEIDSSCGINEVVIWFGKALNILN
TSNSFVEEYQNSGPISLISKKDNLSEPNIEIDDIPDSLLGLSFKDLNNKLYEIYSKNIVY
FKKIYFNFLDQWWTEYYSQYFELICMAKQSILAQESLVKQIIQNKFTDLSKASIPPDTLK
LIKETTEKTFIDLSKESQISMNRVDNFLNKASICVFVEDIYPKFISYMEKYINNINIKTR
EFIQRCTNINDNEKSILINSYTFKTIDFKFLDIQGIKNFFNSQVEQVMKEMLSPYQLLLF
ATRGPNSNIIEDISGKNTLIQYTESVELVYGVNGESLYLKSPNETVEFSNNFFTNGLTNN
FTICFWLRFTGKDDDKTRLIGNKVNNCGWEIYFEDSGLVFEIIDSNGNQESVYLSNVINN
NWYYISISVDRLKDQLLIFINDKNVANVSIEQILNIYSTNVISLVNKNNSIYVEELSVLD
KTVTSEEVIRNYFSYLDNSYIRDSSKSLLEYNKNYQLYNYVFPKTSLYEVNDNNKSYLSL
KNTDGINIPSVKFKLINIDESKGYVQKWDECIICVSDGTEKYLDISPENNRIQLVSSKDN
AKKITVNTDLFRPDCITFSYNDKYFSLSLRDGDYNWMICNDNNKVPKGAHLWILES*
>PROKKA_00008 Botulinum neurotoxin type D precursor
VDIRKLGDVSIMTWPVKDFNYSDPVNDNDILYLRIPQNKLITTPVKAFMITQNIWVIPER
FSSDANPSLSKPPRPTSKYQSYYDPSYLSTDEQKDTFLKGIIKLFKRINERDIGKKLINY
LVVGSPFMGDSSTPEDTFDFTRHTTNIAVEKFENGSWKVTNIITPSVLIFGPLPNILDYT
ASLTLQGQQSNPSFEGFGTLSILKVAPEFLLTFSDVTSNQSSAVLGKSIFCMDPVIALMH
ELTHSLHQLYGINIPSDKKIRPQVSEGFFSQDGPNVQFEELYTFGGSDVEIIPQIERSQL
REKALGHYKDIAKRLNNINKTIPSSWSSNIDKYKKIFSEKYNFDKDNTGNFVVNIDKFNS
LYSDLTNVMSEVVYSSQYNVKNRTHYFSKHYLPVFANILDDNIYTIRDGFNLTNKGFNIE
NSGQNIERNPALQKLSSESVVDLFTKVCLRLTKNSRDDSTCIKVKNNRLPYVADKDSISQ
EIFESQTITDETNVENYSDNFSLDESILDAKVPTNPEAVDPLLPNVNMEPLNVPGEEEVF
YDDITKDVDYLNSYYYLEAQKLSNNVENITLTTSVEEALGYSNKIYTFLPSLAEKVNKGV
QAGLFLNWANEVVEDFTTNIMKKDTLDKISDVSAIIPYIGPALNIGNSALRGNFKQAFAT
AGVAFLLEGFPEFTIPALGVFTFYSSIQEREKIIKTIENCLEQRVKRWKDSYQWMVSNWL
SRITTQFNHISYQMYDSLSYQADAIKAKIDLEYKKYSGSDKENIKSQVENLKNSLDVKIS
EAMNNINKFIRECSVTYLFKNMLPKVINELNKFDLTTKTELIKLIDSHNIILVGEVDRLK
AKVNESFENTIPFNIFSYTNNSLLKDIINEYFNSINDSKILSLQNKKNALVDTSGYNAEV
RLEGDVQVNTIYTNDFKLSSSGDKIIVNLNNNILYSAIYENSSVSFWIKISKDLTNSHNE
YTIINSIKQNSGWKLCIRNGNIEWILQDINRKYKSLIFDYSESLSHTGYTNKWFFVTITN
NIMGYMKLYINGELKQSERIEDLDEVKLDKTIVFGIDENIDENQMLWIRDFNIFSKELSN
EDINIVYEGQILRNVIKDYWGNPLKFDTKYYIINDNYIDRYIAPKSNILVLVQYPDRSKL
YTGNPITIKSVSDKNPYSRILNGDNIMFHMLYNSGEYMIIRDTDTIYATEGRECSKNCVY
ALKLQSNLGNYGIGIFSIKNIVSQNKYCSQIFSSFMKNTMLLADIYKPWRFSFENAYTPV
AVTNYETKLLSTSSFWKFISRDPGWVE*
>PROKKA_00009 hypothetical protein
VIEEQQLNKDLKKVKEKFIKALVRTLNEENENRVYDGKKPLDVCFMVSIIDKQLHQYKDF
LEDLSNGYTFNGYEEDESGYSNGKISLFIEKHIEDKESDLWASTYKQDYWYSIEFKYDTK
DWGYCQCEPNDKGYNEEHDCCGETCDWDAPSFAITKEYDLGTCSWDGFQRDYWEYEKMFK
SKEENKNKRVEDEIKERRKQEIKIQIEMLSKELLSLES*
>PROKKA_00010 hypothetical protein
MFYLKGMMKVNNNINVTRLITYYNTNCKHYWIKTRVGLLKNKNKIIKN*
